Sompraz%25252525252525252525252525252525252525252525252525252525252520hp

Sompraz%25252525252525252525252525252525252525252525252525252525252520hp appears to be a misspelling or a non-standard drug name. It is highly likely that you are referring to **esomeprazole**. The following information is based on esomeprazole. ## Overview Esomeprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion. It is available as oral capsules, oral suspension, and intravenous injection. ## Primary Indications * Gastroesophageal reflux disease (GERD) - erosive esophagitis healing and maintenance, symptomatic GERD treatment. * *Helicobacter pylori* eradication (in combination with antibiotics). * Reduction of risk of NSAID-associated gastric ulcers. * Zollinger-Ellison syndrome. ## Adult Dosing * **GERD (healing erosive esophagitis):** 20 mg to 40 mg once daily for 4 to 8 weeks. * **GERD (maintenance of healing):** 20 mg once daily. * **Symptomatic GERD:** 20 mg once daily for 4 weeks. * ***H. pylori* eradication:** 20 mg twice daily for 10 days (in combination with amoxicillin and clarithromycin or other agents). * **NSAID-associated ulcer prevention:** 20 mg once daily. * **Zollinger-Ellison syndrome:** Starting dose 40 mg twice daily. Adjust dose based on patient response; usual dose 40 mg to 80 mg daily. Doses up to 240 mg daily have been given. ## Pediatric Dosing * **GERD (erosive esophagitis healing, age 1 to 11 years):** 10 mg once daily for up to 8 weeks. * **GERD (erosive esophagitis healing, age 12 to 17 years):** 20 mg once daily for up to 8 weeks. * **Symptomatic GERD (age 12 to 17 years):** 20 mg once daily for up to 4 weeks. * **Note:** Dosing for younger children or for other indications may vary and depends on local protocols. ## Dose Adjustments No dose adjustment is typically necessary for hepatic or renal impairment, though caution may be advised in severe hepatic impairment. ## Contraindications * Hypersensitivity to esomeprazole, substituted benzimidazoles, or any component of the formulation. ## Adverse Effects * **Common:** Headache, diarrhea, nausea, abdominal pain, constipation, flatulence, dry mouth. * **Serious:** *Clostridium difficile*-associated diarrhea, bone fractures (hip, wrist, spine), vitamin B12 deficiency, hypomagnesemia (potentially severe), lupus erythematosus (cutaneous and systemic). ## Key Drug Interactions * **Clopidogrel:** Esomeprazole may decrease the antiplatelet effect of clopidogrel. Consider alternative PPIs or dose adjustments if concomitant use is necessary. * **Drugs dependent on gastric pH for absorption:** May decrease absorption of drugs like ketoconazole, itraconazole, posaconazole, and certain HIV protease inhibitors. * **Methotrexate:** PPIs may increase methotrexate levels. * **CYP2C19 substrates:** Esomeprazole is a moderate inhibitor of CYP2C19 and may increase concentrations of drugs metabolized by this enzyme (e.g., citalopram, diazepam, phenytoin). ## Monitoring * Monitor for signs and symptoms of *Clostridium difficile*-associated diarrhea. * Consider monitoring serum magnesium levels, especially with prolonged use or in patients taking diuretics. * Monitor for signs of bone fracture risk, especially with prolonged use. * Consider monitoring vitamin B12 levels with long-term therapy. ## Clinical Pearls * Administer 30-60 minutes before a meal. * For oral suspension, reconstitute as directed and shake well before use. * Long-term PPI use has been associated with an increased risk of fractures, C. difficile infection, vitamin B12 deficiency, and hypomagnesemia. * When used for *H. pylori* eradication, esomeprazole is part of a multi-drug regimen. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider for any medical decisions.